What Causes Dry Skin with Endometriosis?

What Causes Dry Skin with Endometriosis?

Dry skin in endometriosis is primarily caused by estrogen imbalance — both the relative estrogen dominance and the estrogen drops that occur during hormonal therapy — combined with systemic inflammation, elevated prostaglandins, and common nutrient deficiencies like omega-3s, zinc, and vitamin D. Most people will see some improvement once these underlying drivers are identified and corrected; the exception is those whose dry skin is a side effect of GnRH agonist therapy, which intentionally suppresses estrogen and requires a different management strategy.

---

Why Endometriosis Disrupts Skin Hydration

Your skin's moisture barrier depends on a tightly regulated interplay of sex hormones, lipid synthesis, immune signaling, and micronutrient availability. Endometriosis disrupts several of these pathways simultaneously, which is why skin symptoms in this condition can feel stubborn even when topical moisturizers are applied diligently.

Estrogen's Role in Skin Barrier Function

Estrogen is one of the most important hormones for skin health. It stimulates hyaluronic acid synthesis, promotes sebum production, accelerates keratinocyte proliferation, and supports collagen formation — all of which contribute to skin that feels plump and hydrated (Thornton 2013; PMID: 22788714). In endometriosis, estrogen signaling is dysregulated in two opposing ways:

1. Estrogen dominance — elevated systemic estrogen or an imbalanced estrogen-to-progesterone ratio can drive prostaglandin E2 production, which has been shown to impair skin barrier function and increase transepidermal water loss (TEWL) in inflammatory skin conditions (Ricciotti & FitzGerald 2011; PMID: 21364939).
2. Iatrogenic estrogen suppression — hormonal therapies commonly used to manage endometriosis (GnRH agonists like leuprolide, combined oral contraceptives with low ethinyl estradiol) intentionally lower systemic estrogen. The resulting hypoestrogenic state produces many of the same skin symptoms as menopause: thinning, dryness, and reduced elasticity.

A key mechanistic detail worth understanding: estrogen upregulates aquaporin-3, a water channel protein expressed in keratinocytes that directly governs the movement of water and glycerol through the epidermis. When estrogen falls — whether from natural cycle fluctuation or GnRH agonist therapy — aquaporin-3 expression decreases, reducing intrinsic skin hydration independent of any topical intervention. This explains why even patients who moisturize consistently still report persistent dryness during hormonal suppression phases.

Neither estrogen dominance nor estrogen suppression is kind to your skin barrier, which is why dry skin persists across different phases and treatment strategies in endometriosis.

Chronic Inflammation and Prostaglandin Overload

Endometriosis is characterized by a chronically activated immune environment. Peritoneal fluid in women with endometriosis contains elevated concentrations of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and prostaglandin E2 (Kyama et al. 2006; PMID: 16716564). These inflammatory mediators don't stay contained to the pelvis — systemic spillover has been documented, and it matters for skin.

Prostaglandin E2 in particular disrupts the lamellar body secretion process in the stratum corneum, reducing the lipid-rich coating that prevents water loss. Elevated TNF-α promotes keratinocyte apoptosis and slows barrier repair. Mechanistically, TNF-α also downregulates filaggrin — the structural protein that aggregates keratin filaments and releases natural moisturizing factor (NMF) precursors during cornification. Lower filaggrin means less NMF, less amino acid humectancy in the outer skin layer, and higher TEWL even when lipid levels appear adequate. People with endometriosis often describe skin that feels reactive, easily irritated, and perpetually dehydrated — all consistent with a systemically inflamed skin barrier. This symptom pattern overlaps with what causes itchy skin with endometriosis, where the same prostaglandin and immune pathways trigger sensory symptoms alongside dryness.

---

Key Biomarkers to Check When Skin Is Dry

If you have endometriosis and dry skin, the following labs are the most diagnostically useful. Most can be ordered through a functional medicine provider or platforms like Function Health.

Thyroid function (TSH, free T3, free T4) is also worth checking — hypothyroidism co-occurs with endometriosis at higher-than-chance rates and is itself a major driver of dry skin. The dry skin in perimenopause with hypothyroidism pattern often shares mechanistic overlap with endometriosis-related skin dryness, particularly in the subset of patients on estrogen-suppressing therapy.

Note on ferritin: heavy menstrual bleeding is common in endometriosis and systematically depletes iron stores. Ferritin below 30 ng/mL is enough to impair skin cell turnover even when hemoglobin remains in the normal range. Requesting a full iron panel — not just CBC — is essential, particularly if dryness is accompanied by brittle nails or hair shedding. You can read more about how similar deficiencies manifest in what causes brittle nails with endometriosis.

---

Nutrient Deficiencies That Amplify Dry Skin in Endometriosis

Omega-3 Fatty Acids

EPA and DHA are incorporated into skin cell membranes, reducing the production of inflammatory leukotrienes and supporting the lipid lamellae of the stratum corneum. A randomized trial found that omega-3 supplementation (3.8 g/day EPA + 0.6 g/day DHA for 12 weeks) significantly reduced skin redness and improved hydration in women with sensitive skin (Neukam et al. 2011; PMID: 21088453). In that trial, TEWL decreased by a statistically significant margin by week 12, and the effect was largest in participants who started with the lowest baseline omega-3 index — consistent with a repletion-dependent mechanism rather than a pharmacological one. In endometriosis specifically, omega-3s have also been shown to reduce prostaglandin E2 synthesis, addressing both the skin and pelvic inflammation simultaneously.

Vitamin D3

Vitamin D receptors are expressed on keratinocytes and fibroblasts throughout the skin. Deficiency impairs the differentiation of keratinocytes into the fully formed, lipid-secreting cells that make up the outer skin barrier. A meta-analysis confirmed that vitamin D deficiency is significantly more prevalent in women with endometriosis than in controls (Harris et al. 2013; PMID: 23334113), making supplementation a reasonable first step when 25-OH D is below 40 ng/mL. Importantly, vitamin D also regulates cathelicidin and defensin expression in keratinocytes — antimicrobial peptides that also modulate local skin inflammation. Deficiency in this pathway can make the skin's immune response dysregulated, contributing to the reactive, easily irritated quality many endometriosis patients describe.

Zinc

Zinc is essential for keratinocyte proliferation, wound healing, and the activity of antioxidant enzymes in skin. People with endometriosis have been found to have lower serum zinc compared to controls, likely due to increased utilization during immune activation (Messalli et al. 2014; PMID: 24163044). Zinc deficiency produces characteristic dry, flaky, and slow-healing skin — symptoms that mirror what many endometriosis patients report. Zinc also acts as a 5-alpha-reductase inhibitor, which affects sebum composition; insufficient zinc can shift sebum toward a more pro-inflammatory lipid profile independent of hormonal status, compounding the dryness driven by estrogen dysregulation.

---

The Protocol: From Biomarker to Daily Action

Addressing dry skin in endometriosis means working at three levels: anti-inflammatory foundation, targeted nutrient repletion, and topical barrier support.

1. Run the biomarker panel above before supplementing. Supplementing zinc without knowing your baseline can displace copper; high-dose vitamin D without K2 raises cardiovascular risk over time.
2. Reduce dietary arachidonic acid (processed meats, vegetable oils high in omega-6) to lower prostaglandin E2 precursor load. A practical target is keeping the omega-6 to omega-3 dietary ratio below 4:1; most Western diets run 15:1 or higher.
3. Supplement EPA/DHA at a minimum of 2 g combined daily from a triglyceride-form fish oil. Higher ratios of EPA:DHA (≥2:1) are more effective for inflammation than DHA-dominant formulas. Individuals with documented omega-3 index below 4% may need 4–6 weeks at 3–4 g/day before index meaningfully rises.
4. Correct vitamin D deficiency using D3 paired with K2 (MK-7 form) to support calcium handling. Most adults need 2,000–4,000 IU D3 to move from deficient to optimal range, though individuals with gut absorption issues or obesity may need higher doses supervised by a provider.
5. Restore zinc at 15–30 mg elemental zinc (glycinate or picolinate form) with meals to reduce GI irritation. If supplementing for more than 8 weeks, include 1–2 mg copper to prevent displacement.
6. Support topical barrier repair with ceramide-containing moisturizers applied within 3 minutes of bathing to seal in transepidermal moisture. Ceramides NP, AP, and EOP are the isoforms most directly analogous to the stratum corneum's native lipid composition.
7. Address ferritin if below 30 ng/mL — iron bisglycinate is the best-tolerated oral form. Skin cell turnover requires adequate ferritin-dependent enzymatic activity, and low iron dryness will not fully resolve with topical interventions alone.

If dry skin is severe and co-occurs with hair thinning, low mood, or fatigue, consult your healthcare provider about thyroid function. Similar patterns are documented in what causes dry skin with fibroids and what causes dry skin in postpartum, both of which share the hormone–inflammation–nutrient-depletion triad.

---

The Nootropic Ingredient Angle: When Skin Health Research Overlaps with Systemic Inflammation

Some secondary keywords in the endometriosis skin health conversation reference ingredients more commonly studied for cognitive function. Here is what the evidence actually shows and how it relates — or doesn't — to dry skin with endometriosis.

Citicoline for Skin

Citicoline (CDP-choline) is primarily studied as a neuroprotective compound that supports phosphatidylcholine synthesis in cell membranes. Its relevance to dry skin is indirect but biologically plausible: phosphatidylcholine is a structural component of the lamellar lipid bilayers in the stratum corneum that create the skin's moisture barrier. In vitro data suggest that citicoline may support phospholipid turnover in keratinocytes, but there are no published clinical trials evaluating citicoline specifically for dry skin in endometriosis or any hormonal condition. Its primary role remains in neurological support, and any skin benefit — if present — would likely be a downstream effect of systemic phospholipid availability rather than a direct dermatological action.

Huperzine A for Skin

Huperzine A is an acetylcholinesterase inhibitor derived from Huperzia serrata and is investigated almost exclusively in the context of cognitive decline and Alzheimer's disease. Its connection to skin in endometriosis is not supported by direct evidence. Acetylcholine does have peripheral roles in skin hydration — it is released by keratinocytes and modulates skin moisture balance through muscarinic receptors — but this is a mechanistic curiosity, not a therapeutic pathway with clinical trial data supporting supplementation. People with endometriosis seeking dry skin relief should not prioritize huperzine A over the estrogen, omega-3, and zinc pathways described above.

Noopept for Skin

Noopept is a synthetic peptide with neuroprotective activity, modulating NGF and BDNF expression in animal models. It has no meaningful evidence base for skin health or endometriosis management. Its appearance in searches about endometriosis skin symptoms almost certainly reflects overlap between supplement research communities rather than a genuine clinical connection. There is no rationale to include noopept in a dry-skin-focused protocol for endometriosis patients, and doing so would represent unsupported off-label use of a compound with limited human safety data.

Cordyceps for Skin

Cordyceps (Cordyceps sinensis or Cordyceps militaris) is a medicinal mushroom with documented anti-inflammatory and adaptogenic properties. Unlike the three compounds above, cordyceps has a more plausible mechanistic connection to endometriosis-related skin dryness. Cordyceps extracts have been shown to suppress NF-κB signaling and reduce TNF-α and IL-6 in animal and in vitro models (Olatunji et al., Journal of Ethnopharmacology 2018; PMID: 29719630), directly targeting the inflammatory cytokines elevated in endometriosis peritoneal fluid. A separate in vivo study found that cordyceps polysaccharides reduced oxidative stress markers and inflammatory mediators in a dose-dependent manner in murine models of systemic inflammation (Zhou et al., Evidence-Based Complementary and Alternative Medicine 2015; PMID: 26106438). Reduced systemic inflammatory load would, over time, support filaggrin expression, barrier repair, and reduced TEWL. Human clinical trials in endometriosis specifically are lacking, but cordyceps is the most evidence-adjacent choice among the nootropic compounds listed here if anti-inflammatory systemic support is the goal.

---

What This Means for Your Formula

Ones uses an AI-driven assessment of your lab work, wearable data, and symptom history to build a personalized daily capsule formula. For someone presenting with endometriosis, elevated hs-CRP, low vitamin D, and dry skin, a Ones formula is likely to include:

• Omega-3 (EPA/DHA) — Ones uses a triglyceride-form fish oil dosed to clinically meaningful EPA levels, targeting the prostaglandin E2 suppression documented in inflammatory conditions and directly addressing skin barrier lipid depletion. The EPA:DHA ratio in the Ones formulation is calibrated toward the anti-inflammatory end, consistent with the evidence reviewed above.
• Vitamin D3 + K2 (MK-7) — paired at clinically appropriate doses so that vitamin D repletion occurs alongside cofactor support for calcium metabolism. The K2 pairing is particularly relevant for endometriosis patients on long-term hormonal suppression that may affect both bone density and skin barrier signaling through VDR-mediated pathways.
• Zinc — included at 15–30 mg in a bioavailable form when zinc insufficiency is flagged by lab data, addressing the documented deficit in immune-activated endometriosis patients (Messalli et al. 2014). Copper status is factored into whether zinc is included alone or alongside a balancing cofactor.

Because Ones formulas are calibrated to your actual biomarker findings rather than generic symptom categories, someone whose dry skin is driven by medication-induced estrogen suppression will receive a different formula composition than someone whose dry skin maps to a low omega-3 index and elevated hs-CRP. That individualization — grounded in your specific numbers — is the central value of the platform.

---

Key Takeaways

• Estrogen dysregulation is the primary driver of dry skin in endometriosis — both estrogen dominance (via prostaglandin E2 and impaired lamellar body secretion) and estrogen suppression (via reduced aquaporin-3 and hyaluronic acid synthesis) compromise the skin barrier through distinct but overlapping mechanisms.
• Chronic systemic inflammation — elevated IL-6, TNF-α, and prostaglandin E2 — impairs the stratum corneum's lipid barrier, downregulates filaggrin, and accelerates transepidermal water loss beyond what topical moisturizers can compensate for.
• Three nutrient deficiencies matter most: omega-3 fatty acids, vitamin D3, and zinc — all measurably lower in endometriosis populations and all directly involved in skin barrier integrity through distinct mechanisms.
• Check your biomarkers first: estradiol, 25-OH vitamin D, serum zinc, omega-3 index, ferritin, and hs-CRP give you the clearest picture of which driver dominates in your case — and which supplement strategy will actually work.
• Nootropic ingredients like citicoline, huperzine A, and noopept have no meaningful clinical evidence for dry skin in endometriosis; cordyceps has a more plausible anti-inflammatory rationale via NF-κB and TNF-α suppression but still lacks direct human trial data in this population.
• A personalized approach that matches supplement doses to your actual lab findings — rather than generic endometriosis supplement stacks — produces more reliable outcomes and avoids nutrient interactions like zinc-copper displacement.

Always consult a healthcare provider before making changes to your supplement or hormone therapy regimen, particularly if you are being treated for endometriosis with prescription medications.